company? Let’s change
that.
Don't see your company?
Create a company profileTempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make near real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+ consultants around the world through our Nextcontinent partnership, we work where you do to deliver the change you seek.
CancerIQ helps providers use genetic information to predict, pre-empt, and prevent disease - starting with cancer. By making is easier to identify patients at risk, offer genetic evaluations at point of care, and design a tailored cancer prevention plan - we can help healthcare systems get ahead of this costly and emotionally devastating disease.
Citrine Informatics is the award-winning materials informatics platform for data-driven materials and chemicals development. It won the 2017 World Materials Forum Start-up Challenge, the 2018 AI Breakthrough award as the "Best AI-based Solution for Manufacturing," and 2020-2021 Cleantech 100 honors. The Citrine Platform combines smart materials data infrastructure and AI, which accelerates development of cutting-edge materials, facilitates product portfolio optimization, and codifies research IP, enabling its reuse and preventing its loss. Citrine's customers include Panasonic, Michelin, LANXESS, and some of the biggest and most respected names in the materials and chemicals industry in Asia, North America, and Europe.
Nature’s Fynd is a groundbreaking food tech company born out of NASA-supported research on extremophiles in the geothermal pools of Yellowstone National park. Our novel fermentation technology produces a sustainable source of complete protein using only a fraction of the resources required by traditional agriculture. As the challenge to feed the world’s expanding population grows, our mission is to create amazing food and materials that provide sustainable choices and nurture the planet.
Established in 2001, Avalere Health is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Our team of 1,500+ experts combine their knowledge and expertise across our core disciplines—Consulting; Medical; Policy; Value, Evidence, and Access; Marketing; and Digital Experience Technology—to create the connections that make better health happen. We partner with our clients to navigate the complex and rapidly changing healthcare ecosystem. Together, our experts help clients connect patients with life-changing therapies, realizing the potential of strategies and solutions to accelerate innovation that improves lives.
Sigenics was established in December 2000 with one purpose in mind: to provide excellence in silicon. In the beginning, Sigenics’ goal was to develop silicon devices to aid in biomedical research. We have grown to become a designer and supplier of “private-label” silicon chips for Original Equipment Manufacturers (OEM) of electronic equipment in multiple markets including: medical, aerospace, industrial, and military. Today, Sigenics Inc. is an ISO 9001:2015 certified company that specializes in designing, testing and delivering custom integrated circuits for sensor, analog and mixed-signal applications. Here at Sigenics we pride ourselves on transforming ideas into realities. Sigenics enhances the value of customers’ products at every phase - specification, design, simulation, layout, and testing - and continues this process until the products’ requirements are satisfied. Privately-held, Sigenics is headquartered in Chicago,IL with an additional design office in Los Osos, CA.
PF is a consulting firm providing biomanufacturing strategy and execution. Our services include turnkey capital projects and facility builds; owner's representation and program/project management; validation; quality, regulatory and compliance; engineering and automation and more. We partner with startup and established pharmaceutical companies, advanced therapy companies, academia, hospitals, financial institutions, and CROs/CMOs. One of our core values is giving back. Volunteering at hospitals, supporting healthcare-related fundraisers and partnering with nonprofit organizations is an integral part of our culture. In doing so, not only do we raise awareness of many life-threatening diseases, but we also bring our team and our client’s team closer to the actual patients and families that will be impacted by our work. Project Farma is a Precision for Medicine company and part of Precision ADVANCE, the cell & gene therapy collective™ (https://www.precisionmedicinegrp.com/advance/)
Advanced Clinical is a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey. Our goal is to improve the lives of all those touched by clinical research – approaching each opportunity with foresight, character, resilience and innovation. Based on decades of experience, we help our clients achieve better outcomes by conducting candid conversations and anticipating potential issues through our customized solutions. Visit our website to learn more: www.advancedclinical.com.
Portal Innovations is a venture capital firm that helps exceptional life sciences innovators build their companies where they live. We surround these entrepreneurs with the resources and community they need: Seed capital, fully equipped lab space, and expertise and introductions to other investors and partners.
Exovita Biosciences is an early-stage biotech company developing exosome-based cancer therapeutics.
It’s not a debate. There’s no two sides. A post-pollution world is inevitable. Humans will either be part of it, or the planet will go on without us. In other words, it’s defossilize or die. But where others see a dire choice, LanzaTech sees a trillion-dollar opportunity. The good news is after 15 years, north of a thousand patents, and millions of hours of pioneering scientific inquiry, LanzaTech has invented a technology big enough to meet the moment. One that transforms pollution into profit, and ensures that humans continue to prosper far into the post-pollution future. The science is state-of-the-art, but the idea is simple. We use nature to heal nature. First we capture carbon emissions. Then we feed them into bioreactors where trillions of carbon-hungry microbes go to work. These tiny dynamos eat the pollution and output valuable raw material commodities. Pure enough to be resold, repurposed, recycled, renewed, re-everythinged — from sustainable jet fuel to yoga pants. It’s a commercial scale solution that’s ready for market today. In a crowded sector filled with speculation but short on results, our plug-and-play platform is already making our customers money. Turns out science and business makes one helluva team. Waste carbon pollution is humanity’s biggest threat. LanzaTech is turning it into an opportunity. Reducing emissions and making money for our customers — today. Let's transform our tired Lose-Lose climate debate into a Win-Win proposition. One that helps companies grow their revenue while helping the planet reach a post-pollution reality.
Pioneering Diagnostics A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market.
We help health & wellness companies find their authentic edge and leverage it for growth. EnticEdge is a boutique consulting firm that brings together value-focused strategy and customer-centered design. We customize effective approaches for our clients to convert new customers and further grow their businesses. Our strategic team has decades of experience helping healthcare and wellness companies redefine their value and create compelling messaging around what differentiates them from the competition. With vast knowledge of the healthcare ecosystem, and wellness space, we advise on redefining company or division strategies around your unique value in the marketplace, building meaningful partnerships, helping align stakeholders, and successfully engaging with new innovations - from new incentive models to new technology integration.
As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to devise the best gene delivery solutions for our customers. As a result, we have received glowing customer testimonials and numerous citations in high-impact publications. Operating as a multinational company with branches in North America, Europe, China, Japan, South Korea, Australia and Israel, VectorBuilder has served over 50,000 customers from several thousand organization worldwide, including universities, research institutions, biotech/pharma companies, and governmental agencies. So we ask you one question: Will you join us in the gene delivery revolution?
Surgalign Spine Technologies, Inc., a global, pure-play spine company, is focused and aligned to change and advance the science of spine care. The company designs and manufactures a broad portfolio of innovative devices and tools surgeons use to restore mobility and alleviate pain for their patients. Founded in July 2020, but with a legacy of clinically validated innovation stretching back 30 years, Surgalign invests in advancing care and elevating outcomes. Surgalign markets its products in the United States and in more than 50 countries globally through a growing network of top independent distributors. The company is headquartered in Deerfield, Ill., and has a design center in Wurmlingen, Germany. Surgalign is also a member of AdvaMed.
JDP Therapeutics develops small molecule therapeutics for the treatment of life threatening diseases with unmet medical needs.
Emalex Biosciences, LLC is a biopharmaceutical company dedicated to the development of new treatments for rare and orphan neurological conditions. Ecopipam, its first development candidate, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome. The latter is a childhood-onset neurodevelopmental condition characterized by motor and vocal tics for which very few safe and effective therapies exist.
In a rapidly changing industry, caregivers remain the constant. Every day they demonstrate their passion for helping people despite unprecedented pressure to increase access and quality of care with the same or fewer resources. Hillrom is driven by patient-centered care. Everything we do, and all our products and technologies, are designed to enhance outcomes for patients and caregivers. It starts with cutting through complexity and focusing on the human side of healthcare. By continuously advancing and integrating our solutions, we enable clinicians to be vitally connected to their patients by delivering timely data and actionable insights. That means more accurate diagnoses, earlier intervention and faster recovery times. Our innovations put more heart in healthcare. Through more intelligent—and more connected—solutions, we help simplify routine workflows and communication, enabling care teams to focus on their passion—helping patients get better sooner. And we continuously raise the bar on quality and safety, building upon our legacy of trust with providers around the world. As healthcare continues to evolve, we’re here to support the people at the heart of it. Hillrom. Advancing Connected Care™.
At Horizon Therapeutics, we believe science and compassion must work together to transform lives. We are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. For us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.
Work Your Passion. Live Your Purpose.